Substance
ID:348342
Names and Identifiers
IUPAC name
3-tert-butyl-1-(2-{[4-(diethylamino)butyl]amino}-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl)urea
IUPAC Traditional name
3-tert-butyl-1-(2-{[4-(diethylamino)butyl]amino}-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl)urea
Synonyms
PD 173074N-[2-[[4-(Diethylamino)butyl]amino-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]-N′-(1,1-dimethylethyl)urea
Properties
Product Information
Purity
≥98% (HPLC)
Empirical Formula (Hill Notation)
C28H41N7O3
Physical Property
Apperance
yellow solid
Solubility
DMSO: soluble21 mg/mL
Safety Information
European Hazard Symbols
Irritant (Xi)GHS Pictograms
Acute toxicity (oral, dermal, inhalation), category 4
Skin irritation, category 2
Eye irritation, category 2
Skin sensitisation, category 1
Specific Target Organ Toxicity – Single exposure, category 3
Risk Statements
36/37/38
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
German water hazard class
3
GHS Signal Word
Warning
GHS Hazard statements
H315-H319-H335
Storage Temperature
2-8°C
Safety Statements
26
MSDS Link
GHS Precautionary statements
P261-P305+P351+P338
Pharmacology Properties
Gene Information
human ... FGFR1(2260), KDR(3791)mouse ... Pdgfrb(18596)
Molecule Details
Biochem/physiol Actions
PD 173074 is a fibroblast growth factor receptor 3 (FGFR3) inhibitor: IC50 = 5 nM inhibition of FGFR3 autophosphorylation. PD 173074 arrests the G0/G1 phase of FGFR3-expressing cells. It is 100-fold more selective for FGFR3 than for VEGF receptors, IGF-1 receptors, and MAPKs.
PD 173074 is a fibroblast growth factor receptor 3 (FGFR3) inhibitor: IC50 = 5 nM inhibition of FGFR3 autophosphorylation. PD 173074 arrests the G0/G1 phase of FGFR3-expressing cells. It is 100-fold more selective for FGFR3 than for VEGF receptors, IGF-1 receptors, and MAPKs.
Molecular Spectra
No Data Available
Click here to submit data
References
No Data Available
Click here to submit data